Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05586503 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

EASYII - E-tegra Stent Graft System - Imaging Cohort

Study acronym: EASYII
StatusActive, Not Recruiting
PhaseNot applicable
SponsorJOTEC GmbH
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Dec 31, 2024 to Sep 30, 2029
    • Trial status: Recruiting to Active, Not Recruiting
    • Study sites: 5 to 4
    • Study completion date: Oct 2029 to Dec 2029
    v4
  2. Primary completion date: Dec 31, 2023 to Dec 31, 2024
    • Study sites: 4 to 5
    v3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Primary completion date: Dec 2024 to Dec 31, 2023
    • Start date changed from estimate of Oct 2022 to Dec 16, 2022
    • Site details revised at 4 of 4 sites
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
JOTEC GmbH
14 trials monitored
See 1 trial at risk
The objective of the study is to assess the stent stability and durability as well as the seal of the stent graft during the cardiac cycle and over time as well as to evaluate safety and clinical performance of the E-tegra Stent Graft System used in endovascular treatment of infrarenal aortic aneurysm.
Trial Details
NCT Number NCT05586503
Lead Sponsor JOTEC GmbH
Conditions
(from sponsor)		 Vascular Aneurysm
Related terms Aneurysm
Enrollment 25 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov